Fielder Capital Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-263
Closed -$276K 228
2024
Q3
$276K Sell
263
-1
-0.4% -$1.05K 0.09% 144
2024
Q2
$277K Buy
264
+4
+2% +$4.2K 0.11% 130
2024
Q1
$250K Sell
260
-4
-2% -$3.85K 0.11% 128
2023
Q4
$232K Buy
+264
New +$232K 0.14% 119